
Alcon Hits Milestone, Surpasses 175 Million Intraocular Lens Implants Globally
Published on March 11, 2026
GENEVA—Alcon, a global leader in eyecare, has announced that it has implanted more than 175 million of its intraocular lenses (IOLs) worldwide. This milestone includes more than 6 million of Alcon’s latest-generation of presbyopia-correcting IOLs (PCIOLs) that have been implanted globally, helping patients attain greater visual freedom after cataract surgery, the company advised. With more than 30 years of IOL experience, Alcon’s portfolio includes the Clareon and AcrySof IQ families of IOLs, including Monofocal, Vivity, PanOptix and PanOptix Pro, all with toric options and ultraviolet (UVA) and blue light filtering (BLF) technologies.
